نتائج البحث - Cory M. Johannessen

تنقيح النتائج
  1. 1
    A Convergence-Based Framework for Cancer Drug Resistance

    A Convergence-Based Framework for Cancer Drug Resistance حسب David J. Konieczkowski, Cory M. Johannessen, Levi A. Garraway

    منشور في 2018
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1

    Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1 حسب Avi Sofer, Kui Lei, Cory M. Johannessen, Leif W. Ellisen

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    The NF1 tumor suppressor critically regulates TSC2 and mTOR

    The NF1 tumor suppressor critically regulates TSC2 and mTOR حسب Cory M. Johannessen, Elizabeth E. Reczek, Marianne F. James, Hilde Brems, Eric Legius, Karen Cichowski

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Tumor-Specific p73 Up-regulation Mediates p63 Dependence in Squamous Cell Carcinoma

    Tumor-Specific p73 Up-regulation Mediates p63 Dependence in Squamous Cell Carcinoma حسب M. Phillip DeYoung, Cory M. Johannessen, Chee‐Onn Leong, William C. Faquin, James W. Rocco, Leif W. Ellisen

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Creation of Novel Protein Variants with CRISPR/Cas9-Mediated Mutagenesis: Turning a Screening By-Product into a Discovery Tool

    Creation of Novel Protein Variants with CRISPR/Cas9-Mediated Mutagenesis: Turning a Screening By-Product into a Discovery Tool حسب Katherine Donovan, Mudra Hegde, Meagan E. Sullender, Emma W Vaimberg, Cory M. Johannessen, David E. Root, John G. Doench

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    REDD1, a Developmentally Regulated Transcriptional Target of p63 and p53, Links p63 to Regulation of Reactive Oxygen Species

    REDD1, a Developmentally Regulated Transcriptional Target of p63 and p53, Links p63 to Regulation of Reactive Oxygen Species حسب Leif W. Ellisen, Kate D Ramsayer, Cory M. Johannessen, Annie Yang, Hideyuki Beppu, Karolina Minda, Jonathan D. Oliner, Frank McKeon, Daniel A. Haber

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    A negative feedback signaling network underlies oncogene-induced senescence

    A negative feedback signaling network underlies oncogene-induced senescence حسب Stéphanie Courtois-Cox, Sybil M. Genther Williams, Elizabeth E. Reczek, Bryan W. Johnson, Lauren T. McGillicuddy, Cory M. Johannessen, Pablo E. Hollstein, Mia MacCollin, Karen Cichowski

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

    A melanocyte lineage program confers resistance to MAP kinase pathway inhibition حسب Cory M. Johannessen, Laura A. Johnson, Federica Piccioni, Aisha Townes, Dennie T. Frederick, Melanie Donahue, Rajiv Narayan, Keith T. Flaherty, Jennifer A. Wargo, David E. Root, Levi A. Garraway

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    A Functional Landscape of Resistance to MEK1/2 and CDK4/6 Inhibition in NRAS-Mutant Melanoma

    A Functional Landscape of Resistance to MEK1/2 and CDK4/6 Inhibition in NRAS-Mutant Melanoma حسب Tikvah K. Hayes, Flora Luo, Ofir Cohen, Amy Goodale, Yenarae Lee, Sasha Pantel, Mukta Bagul, Federica Piccioni, David E. Root, Levi A. Garraway, Matthew Meyerson, Cory M. Johannessen

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    TORC1 Is Essential for NF1-Associated Malignancies

    TORC1 Is Essential for NF1-Associated Malignancies حسب Cory M. Johannessen, Bryan W. Johnson, Sybil M. Genther Williams, Annie W. Chan, Elizabeth E. Reczek, Ryan C. Lynch, Matthew J. Rioth, Andrea I. McClatchey, Sandra Ryeom, Karen Cichowski

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling

    Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling حسب Nikhil Wagle, W. Marston Linehan, Michael F. Berger, Matthew J. Davis, Allison M. Sawyer, Panisa Pochanard, Sarah M. Kehoe, Cory M. Johannessen, Laura E. MacConaill, William C. Hahn, Matthew Meyerson, Levi A. Garraway

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Phenotypic Characterization of a Comprehensive Set of MAPK1 /ERK2 Missense Mutants

    Phenotypic Characterization of a Comprehensive Set of MAPK1 /ERK2 Missense Mutants حسب Lisa Brenan, Aleksandr Andreev, Ofir Cohen, Sasha Pantel, Atanas Kamburov, Davide Cacchiarelli, Nicole S. Persky, Cong Zhu, Mukta Bagul, Eva M. Goetz, Alex B. Burgin, Levi A. Garraway, Gad Getz, Tarjei S. Mikkelsen, Federica Piccioni, David E. Root, Cory M. Johannessen

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance

    DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance حسب Katsuhiro Togami, Timothy J. Pastika, Jason Stephansky, Mahmoud Ghandi, Amanda L. Christie, Kristen L. Jones, C. Anderson Johnson, Ross Lindsay, Christopher Brooks, Anthony Letai, Jeffrey W. Craig, Olga Pozdnyakova, David M. Weinstock, Joan Montero, Jon C. Aster, Cory M. Johannessen, Andrew A. Lane

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors

    A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors حسب David J. Konieczkowski, Cory M. Johannessen, Omar O. Abudayyeh, Jong Wook Kim, Zachary A. Cooper, Adriano Piris, Dennie T. Frederick, Michal Barzily-Rokni, Ravid Straussman, Rizwan Haq, David E. Fisher, Jill P. Mesirov, William C. Hahn, Keith T. Flaherty, Jennifer A. Wargo, Pablo Tamayo, Levi A. Garraway

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer

    A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer حسب Frederick H. Wilson, Cory M. Johannessen, Federica Piccioni, Pablo Tamayo, Jong Wook Kim, Eliezer M. Van Allen, Steven M. Corsello, Marzia Capelletti, Antonio Calles, Mohit Butaney, Tanaz Sharifnia, Stacey B. Gabriel, Jill P. Mesirov, William C. Hahn, Jeffrey A. Engelman, Matthew Meyerson, David E. Root, Pasi A. Jänne, Levi A. Garraway

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    A public genome-scale lentiviral expression library of human ORFs

    A public genome-scale lentiviral expression library of human ORFs حسب Xiaoping Yang, Jesse S. Boehm, Xinping Yang, Kourosh Salehi‐Ashtiani, Tong Hao, Yun Shen, Rakela Lubonja, Sapana Thomas, Ozan Alkan, Tashfeen Bhimdi, Thomas Green, Cory M. Johannessen, Serena J. Silver, Cindy M. Nguyen, Ryan R. Murray, Haley Hieronymus, Dawit Balcha, Changyu Fan, Chenwei Lin, Lila Ghamsari, Marc Vidal, William C. Hahn, David E. Hill, David E. Root

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling

    Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling حسب Amanda Balboni Iniguez, Gabriela Alexe, Emily Jue Wang, Giovanni Roti, Sarvagna Patel, Liying Chen, Samuel Kitara, Amy Saur Conway, Amanda L. Robichaud, Björn Stolte, Pratiti Bandopadhayay, Amy Goodale, Sasha Pantel, Yenarae Lee, Dorian M. Cheff, Matthew D. Hall, Rajarshi Guha, Mindy I. Davis, Marie Ménard, Nicole Nasholm, William A. Weiss, Jun Qi, Rameen Beroukhim, Federica Piccioni, Cory M. Johannessen, Kimberly Stegmaier

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

    Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants حسب Tikvah K. Hayes, Elisa Aquilanti, Nicole S. Persky, Xiaoping Yang, Erica Kim, Lisa Brenan, Amy Goodale, Douglas Alan, Ted Sharpe, Robert Shue, Lindsay Westlake, Lior Golomb, Brianna Silverman, Myshal D. Morris, Ty Running Fisher, Eden Beyene, Yvonne Li, Andrew D. Cherniack, Federica Piccioni, J. Kevin Hicks, Andrew Chi, Daniel P. Cahill, Jörg Dietrich, Tracy T. Batchelor, David E. Root, Cory M. Johannessen, Matthew Meyerson

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    MAP Kinase Pathway Alterations in <i>BRAF</i>-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition

    MAP Kinase Pathway Alterations in <i>BRAF</i>-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition حسب Nikhil Wagle, Eliezer M. Van Allen, Daniel J. Treacy, Dennie T. Frederick, Zachary A. Cooper, Amaro Taylor‐Weiner, Mara Rosenberg, Eva M. Goetz, Ryan J. Sullivan, Deborah Farlow, Dennis C. Friedrich, Kristin Anderka, Danielle Perrin, Cory M. Johannessen, Aaron McKenna, Kristian Cibulskis, Gregory V. Kryukov, Eran Hodis, Donald P. Lawrence, Sheila Fisher, Gad Getz, Stacey Gabriel, Scott L. Carter, Keith T. Flaherty, Jennifer A. Wargo, Levi A. Garraway

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Mutational processes shape the landscape of TP53 mutations in human cancer

    Mutational processes shape the landscape of TP53 mutations in human cancer حسب Andrew O. Giacomelli, Xiaoping Yang, Robert Lintner, James M. McFarland, Marc Duby, Jaegil Kim, Thomas P. Howard, David Y. Takeda, Seav Huong Ly, Eejung Kim, Hugh Gannon, Brian Hurhula, Ted Sharpe, Amy Goodale, Briana Fritchman, Scott Steelman, Francisca Vázquez, Aviad Tsherniak, Andrew J. Aguirre, John G. Doench, Federica Piccioni, Charles W.M. Roberts, Matthew Meyerson, Gad Getz, Cory M. Johannessen, David E. Root, William C. Hahn

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: